anti-CD19 CAR-NK Clinical Trials

1 actively recruiting trial

Also known as: CB CAR-NK019

Pipeline

Phase 1: 1

Top Sponsors

Second Affiliated Hospital, School of Medicine, Zhejiang University1

Indications

B-Cell Non-Hodgkin Lymphoma1
Cancer1

Other1 trial

Clinical Study of Cord Blood-derived CAR-NK Cells Targeting CD19 in the Treatment of Refractory/Relapsed B-cell NHL

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.